Interim report Q2, 2023: Strong growth in APAC – Vitrolife AB (publ)

Sales of SEK 905 (829) million, an increase of 9%, or 10% excluding discontinued business. In local currencies the growth was 3% and excluding discontinued business 4%.

Scroll to Top